$Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.$

Risedronate in adults with osteogenesis imperfecta type I: increased bone mineral density and decreased bone turnover, but high fracture rate persists.

UNLABELLED: Bisphosphonates can increase bone mineral density (BMD) in children with osteogenesis imperfecta (OI). In this study of adults with OI type I, risedronate increased BMD at lumbar spine (but not total hip) and decreased bone turnover. However, the fracture rate in these patients remained...

Szczegółowa specyfikacja

Opis bibliograficzny
Główni autorzy:	Bradbury, L, Barlow, S, Geoghegan, F, Hannon, R, Stuckey, S, Wass, J, Russell, R, Brown, M, Duncan, E
Format:	Journal article
Język:	English
Wydane:	2012

Podobne zapisy

The ROSI study (risedronate in adults with osteogenesis imperfecta type 1)
od: Duncan, E, i wsp.
Wydane: (2005)

The ROSI study (Risedronate in adults with osteogenesis imperfecta type 1): Improved BMD but high fracture rate persists.
od: Bradbury, L, i wsp.
Wydane: (2006)

Application of Orthopantomography in the Analysis of Bone Mineral Density in Patients with Osteogenesis Imperfecta
od: Lara García-Boedo, i wsp.
Wydane: (2024-02-01)

Changes of bone turnover markers and bone mineral density among postmenopausal Thai women with osteoporosis receiving generic risedronate
od: Ammarin Suwan, i wsp.
Wydane: (2024-10-01)

The Effects of Risedronate Therapy Combined With Vitamin D and Calcium on Biochemical Markers of Bone Turnover and Bone Mineral Density in Postmenopausal Osteoporosis
od: Hüsniye Koç, i wsp.
Wydane: (2004-12-01)

Complex Analysis of Micronutrient Levels and Bone Mineral Density in Patients with Different Types of Osteogenesis Imperfecta
od: Diana Valeeva, i wsp.
Wydane: (2025-01-01)

Effect of Risedronate on Bone Resorption during the Consolidation Phase of Distraction Osteogenesis: A Rabbit Model
od: Pedram Heidari, i wsp.
Wydane: (2010-08-01)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate: greater increases in bone mineral density do not relate to greater decreases in fracture risk.
od: Watts, N, i wsp.
Wydane: (2004)

Association of trabecular bone score and bone mineral apparent density with the severity of bone fragility in children and adolescents with osteogenesis imperfecta: A cross-sectional study.
od: Yasuhisa Ohata, i wsp.
Wydane: (2023-01-01)

Evaluation of Radiolucent Lesions in Cortices of Long Bones in Osteogenesis Imperfecta Patients
od: Carolyn Cook, MD, i wsp.
Wydane: (2024-11-01)

Wish Bone Day: Raising Awareness for Osteogenesis Imperfecta – Global and India
od: Yuvaraja Murugan, i wsp.
Wydane: (2023-07-01)

Rare coexistence of hypopituitarism with osteogenesis imperfecta – A double-trouble for bone
od: Rajdeep Basu, i wsp.
Wydane: (2024-06-01)

Bone Fractures Numerical Analysis in a Femur Affected by Osteogenesis Imperfecta
od: Viridiana Ramírez-Vela, i wsp.
Wydane: (2021-12-01)

Quantitative increase in T regulatory cells enhances bone remodeling in osteogenesis imperfecta
od: In-Hong Kang, i wsp.
Wydane: (2022-09-01)

Calcitonin in osteogenesis imperfecta.
od: Smith, R, i wsp.
Wydane: (1973)

THE EFFECTIVENESS OF ZINC AND RISEDRONATE ON BONE TURNOVER IN RAT MODEL OF OSTEOPOROSIS ASSESSED WITH THE EXPRESSION OF β-CROSSLAPS
od: Adam Fajar, i wsp.
Wydane: (2019-12-01)

Osteogenesis imperfecta
od: Justin Easow Sam, i wsp.
Wydane: (2017-01-01)

Osteogénesis imperfecta
od: Ernesto Plata Rueda
Wydane: (1952-07-01)

Osteogenesis imperfecta
od: Bruno Kusznir Vitturi, i wsp.
Wydane: (2018-08-01)

Relationship between changes in bone mineral density and vertebral fracture risk associated with risedronate
od: Watts, N, i wsp.
Wydane: (2004)

The Comparison of the Effect of Risedronate and Strontium Ranelate on Bone Mineral Density in Postmenopausal Women
od: Figen Yılmaz, i wsp.
Wydane: (2012-08-01)

Multiple Bone Fractures in a Neonate with Osteogenesis Imperfecta: A Case Report
od: Rakesh Kumar, i wsp.
Wydane: (2021-07-01)

Bone density, fractures and the associated factors in iranian children and adolescent with Osteogenesis Imperfecta
od: Pooran Mohsenzade, i wsp.
Wydane: (2021-01-01)

Bone cell differentiation and mineralization in wild-type and osteogenesis imperfecta zebrafish are compromised by per- and poly-fluoroalkyl substances (PFAS)
od: Francesca Tonelli, i wsp.
Wydane: (2025-01-01)

Risedronate-loaded aerogel scaffolds for bone regeneration
od: Nahla El-Wakil, i wsp.
Wydane: (2023-12-01)

Effect of risedronate on bone loss at discontinuation of denosumab
od: Michel Laroche, i wsp.
Wydane: (2020-12-01)

Hydrocephalus in Osteogenesis Imperfecta
od: J Gordon Millichap
Wydane: (1994-03-01)

Cardiovascular abnormalities in osteogenesis imperfecta.
od: White, N, i wsp.
Wydane: (1983)

Osteogenesis imperfecta in Brazilian patients
od: Maira Trancozo, i wsp.
Wydane: (2019-08-01)

Collagen piezoelectricity in osteogenesis imperfecta and its role in intrafibrillar mineralization
od: Jinha Kwon, i wsp.
Wydane: (2022-11-01)

Persistent Activation of Calcium‐Sensing Receptor Suppresses Bone Turnover, Increases Microcracks, and Decreases Bone Strength
od: Bingzi Dong, i wsp.
Wydane: (2019-07-01)

Utilidad del trabecular bone score en sujetos adultos con osteogénesis imperfecta
od: Florez H, i wsp.
Wydane: (2022-11-01)

X-Ray Densitometry in Assessment of the Structural and Functional State of Bone in the Patients with Osteogenesis Imperfecta
od: Yu.M. Guk, i wsp.
Wydane: (2014-02-01)

Osteogenesis imperfecta and sclerostin antibody – Histological evaluation of the bone-tendon unit in the oim mouse
od: Antoine Chretien, i wsp.
Wydane: (2021-04-01)

Intrauterine Bone Marrow Transplantation in Osteogenesis Imperfecta Mice Yields Donor Osteoclasts and Osteomacs but Not Osteoblasts
od: Susan M. Millard, i wsp.
Wydane: (2015-11-01)

A Multicenter Observational Cohort Study to Evaluate the Effects of Bisphosphonate Exposure on Bone Mineral Density and Other Health Outcomes in Osteogenesis Imperfecta
od: Jaskaran S Bains, i wsp.
Wydane: (2019-05-01)

The vitamin D status in a Chinese osteogenesis imperfecta population and its correlation with bone metabolic markers and bone density
od: Yunyi Jiang, i wsp.
Wydane: (2024-08-01)

Craniofacial Effects of Zoledronic Acid on the Osteogenesis Imperfecta Mouse (−/−) Model of Severe Osteogenesis Imperfecta
od: Gaspard Jeannerod, i wsp.
Wydane: (2024-11-01)

Gene Expression Profile and Acute Gene Expression Response to Sclerostin Inhibition in Osteogenesis Imperfecta Bone
od: Rachel K Surowiec, i wsp.
Wydane: (2020-08-01)

Inhibition of TGF‐β Increases Bone Volume and Strength in a Mouse Model of Osteogenesis Imperfecta
od: Benjamin Greene, i wsp.
Wydane: (2021-09-01)